Transplantation of Human Menstrual Blood-Derived Mesenchymal Stem Cells Alleviates Alzheimer’s Disease-Like Pathology in APP/PS1 Transgenic Mice. This evidence concerns the gene APP and early-onset autosomal dominant Alzheimer disease.